
- September 2009
- Volume 75
- Issue 9
Compounding Hotline
Mr. Erickson is director of professional affairs at Gallipot Inc.
Q:
Could you please cite studies about the delivery of medication rectally using hard gelatin capsules?
A:
Gelatin capsules are dose forms used to administer medications orally. Rectal administration of gelatin powder-filled capsules is not recommended for a variety of reasons, including the tendency for the material to form a bolus, which is expelled before the patient can absorb the drug. The pharmaceutically and medically accepted method for administering medication rectally is by means of a suppository dose form. This dose form is compounded by the pharmacist or is manufactured by melting a suitable vehicle (usually either a hydrogenated vegetable oil or a polyethylene glycol wax derivative) in which the drug(s) and perhaps some excipients are dispersed. When the dose form is administered rectally, the suppository either melts or dissolves, depending upon the vehicle chosen, releasing the drug(s) evenly throughout the patient’s rectum. To reiterate, gelatin capsules are not recommended as a means by which to administer drugs rectally, although occasionally a researcher may attempt to administer a softgel capsule rectally. A literature search performed on the National Library of Medicine Web site revealed essentially no relevant citations relating to rectal administration of medication in gelatin capsules.
E-mail your compounding questions to: compounding@PharmacyTimes.com
Articles in this issue
about 16 years ago
Pain Management Watchabout 16 years ago
GERD Watchabout 16 years ago
Healthy HSP: Antimicrobial Stewardship: The Path of Least Resistanceabout 16 years ago
Diabetes Watchabout 16 years ago
Coagulation Counselingabout 16 years ago
Liability for Dispensing a Withdrawn Drugabout 16 years ago
Health Care Reform: Funding for Specialty Residenciesabout 16 years ago
Prescribed Measures: Identifying and Preventing Prescription Abuseabout 16 years ago
Outlook: Obesity Epidemicabout 16 years ago
A Pharmacist's Guide to OTC Therapy: NSAIDS and Alzheimer's RiskNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































